| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Director | Exit Filing +2 more
4 companies
Tang Kevin is a Chief Executive Officer at Aurinia Pharmaceuticals Inc. with holdings across 4 companies. Recent SEC Form 4 filings include 35 buys and 18 sells.
Estimated insider holdings value: $218.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 2, 2026 | AUPH Aurinia Pharmaceuticals Inc. | Chief Executive Officer | Buy | 814,606 | $15.29 | $12,455,227.01 | +1.3% | - | - | |
| Aug 5, 2025 | AUPH Aurinia Pharmaceuticals Inc. | Director | Buy | 1,300,000 | $10.45 | $13,590,000.00 | +4.0% | +12.6% | - | |
| Mar 4, 2025 | AUPH Aurinia Pharmaceuticals Inc. | Director | Buy | 1,600,000 | $7.95 | $12,713,125.64 | +2.9% | -1.5% | +86.1% | |
| Dec 9, 2024 | AUPH Aurinia Pharmaceuticals Inc. | Director | Buy | 1,200,000 | $9.02 | $10,822,000.00 | +5.3% | -10.5% | +70.1% | |
| Nov 23, 2021 | APVO Aptevo Therapeutics Inc. | Exit Filing | Sell | 921,336 | $11.25 | $10,368,236.34 | -24.2% | -67.7% | -82.6% | |
| Nov 22, 2021 | APVO Aptevo Therapeutics Inc. | 10% Owner | Sell | 838,664 | $7.75 | $6,500,410.92 | -6.2% | -15.1% | -54.8% | |
| Nov 6, 2020 | APVO Aptevo Therapeutics Inc. | 10% Owner | Buy | 1,436,675 | $17.30 | $24,849,231.19 | +8.2% | - | - | |
| Oct 4, 2019 | HRTX Heron Therapeutics, Inc. /de/ | Director | Buy | 285,714 | $17.50 | $4,999,995.00 | +5.2% | - | - | |
| Sep 12, 2018 | HRTX Heron Therapeutics, Inc. /de/ | Director, 10% Owner | Sell | 2,695,000 | $35.75 | $96,346,250.00 | -31.6% | - | - | |
| Mar 29, 2018 | HRTX Heron Therapeutics, Inc. /de/ | Director, 10% Owner | Buy | 192,308 | $26.00 | $5,000,008.00 | +2.3% | - | - |